1. Home
  2. PYPD

as of 11-28-2025 12:26pm EST

$3.85
+$0.05
+1.32%
Stocks Health Care Medical/Dental Instruments Nasdaq

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Chart Type:
Time Range:
Founded: 2008 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 57.8M IPO Year: 2020
Target Price: $12.00 AVG Volume (30 days): 67.8K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.62 EPS Growth: N/A
52 Week Low/High: $2.30 - $3.96 Next Earning Date: 11-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered PYPD Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 61.31%
61.31%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest PolyPid Ltd. News

PYPD Breaking Stock News: Dive into PYPD Ticker-Specific Updates for Smart Investing

All PYPD News

Share on Social Networks: